XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead
3/18/2026
Impact: 75
Healthcare
XOMA Royalty Corporation (NASDAQ: XOMA) reported Q4 earnings of 26 cents per share, surpassing the consensus estimate of a 15 cent loss, and revenue of $13.75 million, exceeding expectations of $11.04 million. The company repurchased 648,048 shares for $16 million and had cash and cash equivalents of $133.7 million as of December 31, 2025. Following the earnings announcement, XOMA shares rose 5.70% to $28.54, with the CEO indicating upcoming catalysts from 14 programs in registrational studies.
AI summary, not financial advice
Share: